Anthony Chilton

Anthony Chilton is the Chief Operating Officer (COO) at Radyus Research, a collaborative research organization that partners with biotech companies.13 Here are some key details about Dr. Chilton:

Professional Experience

Dr. Chilton has over 30 years of experience in the pharmaceutical industry, with 20 years in senior leadership roles across biotech, large pharma, and contract research organizations.14 His expertise includes:

• Preclinical development planning and execution
• Building businesses and developing strategies
• Fostering cross-functional teams
• International life sciences leadership and management

Throughout his career, he has successfully led multiple pharmaceutical programs through preclinical development and into clinical stages.1

Education

• PhD in Analytical Chemistry from the University of Hertfordshire
• BSc Hons in Chemistry from the University of East Anglia1

Skills and Expertise

Dr. Chilton is skilled in:

• Drug discovery and development
• Preclinical and early clinical phase development
• Operational and regulatory experience in Canada, US, and Europe
• ADME/PK, bioanalytical, and preclinical development4

Previous Roles

Before joining Radyus Research, Dr. Chilton held various key positions, including:

• Chief Strategy Officer at NTxBio
• Consultant at BioData Solutions
• Founder at C2K2 Consulting Inc
• Sr Director at Roivant Sciences, Inc.
• CEO/COO at BASi Inc
• Senior Director DM/PK at ATHEROGENICS
• Vice President at Cardinal Health, SPS
• Senior Scientist at Glaxo Smith Kline (GSK)

At Radyus Research, Dr. Chilton is part of a team of experienced drug developers with pharma R&D and venture capital backgrounds, working to guide clients to success and expedite drug development.2